NervGen Pharma Corp. (NGEN)
2.00
0.00 (0.00%)
USD |
NASDAQ |
Aug 25, 10:22
NervGen Pharma Shareholders Equity (Quarterly) : 12.18M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.18M |
| March 31, 2026 | 3.971M |
| December 31, 2025 | 2.536M |
| September 30, 2025 | -2.114M |
| June 30, 2025 | -0.6731M |
| March 31, 2025 | 0.9654M |
| December 31, 2024 | 1.792M |
| September 30, 2024 | 6.794M |
| June 30, 2024 | 9.127M |
| March 31, 2024 | 13.91M |
| December 31, 2023 | -1.524M |
| September 30, 2023 | 3.778M |
| June 30, 2023 | 5.713M |
| March 31, 2023 | 7.300M |
| December 31, 2022 | 9.935M |
| Date | Value |
|---|---|
| September 30, 2022 | 13.40M |
| June 30, 2022 | 7.656M |
| March 31, 2022 | 10.23M |
| December 31, 2021 | 13.31M |
| September 30, 2021 | 6.546M |
| June 30, 2021 | 6.205M |
| March 31, 2021 | 4.097M |
| December 31, 2020 | 4.647M |
| September 30, 2020 | 7.431M |
| June 30, 2020 | 4.098M |
| March 31, 2020 | 3.302M |
| December 31, 2019 | 4.505M |
| September 30, 2019 | 4.899M |
| June 30, 2019 | 6.596M |
| March 31, 2019 | 6.948M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | 6.892M |
| Milestone Pharmaceuticals, Inc. | 18.22M |
| Clearmind Medicine, Inc. | 11.49M |
| Lexaria Bioscience Corp. | 4.738M |
| Target Group, Inc. (Canada) | -8.655M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 63.57M |
| Total Liabilities (Quarterly) | 51.39M |
| Current Ratio | 1.232 |
| Net Debt Paydown Yield | 0.01% |